Impaired vascular function in mice with an active cytomegalovirus infection

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 296, Issue 4, 2009, Pages

  Gombos, R B ^a   Wolan, V ^a   McDonald, K ^a   Hemmings, D G ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Mesenteric arteries; Pregnancy; Pressure myograph; Uterine arteries; Vasodilation

Indexed keywords

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; PHENYLEPHRINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL FUNCTION; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; ENDOTHELIAL DYSFUNCTION; FEMALE; HYPOTENSION; IN VIVO STUDY; MATERNAL DISEASE; MESENTERIC ARTERY; MESENTERY; MOUSE; NONHUMAN; PLACENTA; PLACENTA WEIGHT; PRIORITY JOURNAL; SALIVARY GLAND; THIRD TRIMESTER PREGNANCY; UTERINE ARTERY; VASOCONSTRICTION; VASODILATATION;

ANIMALS; ARTERIES; BETA-GALACTOSIDASE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DISEASE MODELS, ANIMAL; FEMALE; FETAL WEIGHT; MALE; MESENTERY; METHACHOLINE CHLORIDE; MICE; MICE, INBRED C57BL; PHENYLEPHRINE; PLACENTA; PREGNANCY; UTERUS; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS; VASODILATION; VASODILATOR AGENTS;

EID: 66249122417     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.01027.2008     Document Type: Article

References (59)

1. Aiello A, Haan M, Blythe L, Moore K, Gonzalez JM, Jagust W. The influence of latent viral infection on rate of cognitive decline over 4 years. J Am GeriatrSoc 54: 1046-1054, 2006.
2. Anderson CM, Lopez F, Zhang HY, Pavlish K, Benoit JN. Reduced uteroplacental perfusion alters uterine arcuate artery function in the pregnant Sprague-Dawley rat. Biol Reprod 72: 762-766, 2005.
3. Bouhanick B, Chamontin B. Should pulse pressure and day/night variations in blood pressure be seen as independent risk factors requiring correction or simply as markers to be taken into account when evaluating overall vascular risk? Diabetes Metab 33: 321-330, 2007.
4. Brown HL, Abernathy MP. Cytomegalovirus infection. Semin Perinatol 22: 260-266, 1998.
5. Burnett MS, Durrani S, Stabile E, Saji M, Lee CW, Kinnaird TD, Hoffman EP, Epstein SE. Murine cytomegalovirus infection increases aortic expression of proatherosclerotic genes. Circulation 109: 893-897,2004.
6. Campbell WB, Harder DR. Prologue: EDHF-what is it? Am J Physiol Heart Circ Physiol 280: H2413-H2416, 2001.
7. Carbillon L, Uzan M, Uzan S. Pregnancy, vascular tone, and maternal hemodynamics: a crucial adaptation. Obstet Gynecol Surv 55: 574-581, 2000.
8. Chirayath HH, Wareing M, Taggart MJ, Baker PN. Acute hypergly-cemia in uterine arteries from pregnant, but not non-pregnant mice, enhances endothelium-dependent relaxation. Vascul Pharmacol 46: 137143, 2007.
9. Compton T, Kurt-Jones EA, Boehme KW, Belko J, Latz E, Golenbock DT, Finberg RW. Human cytomegalovirus activates inflammatory cyto- kine responses via CD14 and toll-like receptor 2. J Virol 77: 4588 -4596,2003.
10. Cook JL, Zhang Y, Davidge ST. Vascular function in alcohol-treated pregnant and nonpregnant mice. Am J Physiol Regul Integr Comp Physiol 281: R1449-R1455, 2001.
11. Cooke CL, Davidge ST. Pregnancy-induced alterations of vascular function in mouse mesenteric and uterine arteries. Biol Reprod 68: 1072-1077,2003.
12. D'Angelo G, Osol G. Regional variation in resistance artery diameter responses to alpha-adrenergic stimulation during pregnancy. Am J Physiol Heart Circ Physiol 264: H78 -H85, 1993.
13. Davidge ST, McLaughlin MK. Endogenous modulation of the blunted adrenergic response in resistance-sized mesenteric arteries from the pregnant rat. Am J Obstet Gynecol 167: 1691-1698, 1992.
14. Demmler GJ. Infectious Diseases Society of America and Centers for Disease Control. Summary of a workshop on surveillance for congenital cytomegalovirus disease. Rev Infect Dis 13: 315-329, 1991.
15. Espinola-Klein C, Rupprecht HJ, Blankenberg S, Bickel C, Kopp H, Rippin G, Victor A, Hafner G, Schlumberger W, Meyer J. Impact of infectious burden on extent and long-term prognosis of atherosclerosis. Circulation 105: 15-21, 2002.
16. Friedman SA, Taylor RN, Roberts JM. Pathophysiology of preeclamp- sia. Clin Perinatol 18: 661-682, 1991.
17. Grahame-Clarke C. Human cytomegalovirus, endothelial function and atherosclerosis. Herpes 12: 42-45, 2005.
18. Gros R, Van Wert R, You X, Thorin E, Husain M. Effects of age, gender, and blood pressure on myogenic responses of mesenteric arteries from C57BL/6 mice. Am J Physiol Heart Circ Physiol 282: H380-H388, 2002.
19. Grunberger W, Leodolter S, Parschalk O. Maternal hypotension: fetal outcome in treated and untreated cases. Gynecol Obstet Invest 10: 32-38, 1979.
20. Grundy JE, Mackenzie JS, Stanley NF. Influence of H-2 and non-H-2 genes on resistance to murine cytomegalovirus infection. Infect Immun 32: 277-286, 1981.
21. Hemmings DG, Xu Y, Davidge ST. Sphingosine 1-phosphate-induced vasoconstriction is elevated in mesenteric resistance arteries from aged female rats. Br J Pharmacol 143: 276-284, 2004.
22. Hermsteiner M, Zoltan DR, Kunzel W. The vasoconstrictor response of uterine and mesenteric resistance arteries is differentially altered in the course of pregnancy. Eur J Obstet Gynecol Reprod Biol 100: 29 -35, 2001.
23. Hines T, Barron WM. Effect of sinoaortic denervation on pressor responses in pregnant rats. Am J Physiol Regul Integr Comp Physiol 262: R1100-R1105, 1992.
24. Hummel M, Abecassis MM. A model for reactivation of CMV from latency. J Clin Virol 25, Suppl 2: S123-S136, 2002.
25. Johnson KP. Mouse cytomegalovirus: placental infection. J Infect Dis 120: 445-450, 1969.
26. Kim TH, Weiner CP, Thompson LP. Effect of pregnancy on contraction and endothelium-mediated relaxation of renal and mesenteric arteries. Am J Physiol Heart Circ Physiol 267: H41-H47, 1994.
27. Lang U, Baker RS, Braems G, Zygmunt M, Kunzel W, Clark KE.Uterine blood flow-a determinant of fetal growth. Eur J Obstet Gynecol Reprod Biol 110, Suppl 1: S55-S61, 2003.
28. Leung Ki EL, Venetz JP, Meylan P, Lamoth F, Ruiz J, Pascual M. Cytomegalovirus infection and new-onset post-transplant diabetes melli- tus. Clin Transplant 22: 245-249, 2008.
29. Magness RR. Maternal cardiovascular and other physiologic responses to the endocrinology of pregnancy. In: The Endocrinology of Pregnancy, edited by Bazer F. Totowa, NJ: Humana, 1998, p. 507-539.
30. Magness RR, Gant NF. Control of vascular reactivity in pregnancy: the basis for therapeutic approaches to prevent pregnancy-induced hypertension. Semin Perinatol 18: 45-69, 1994.
31. Maser RE, Lenhard MJ. An overview of the effect of weight loss on cardiovascular autonomic function. Curr Diabetes Rev 3: 204-211, 2007.
32. Mehta SK, Stowe RP, Feiveson AH, Tyring SK, Pierson DL. Reactivation and shedding of cytomegalovirus in astronauts during spaceflight. J Infect Dis 182: 1761-1764, 2000.
33. Moretti R, Torre P, Antonello RM, Manganaro D, Vilotti C, Pizzolato G. Risk factors for vascular dementia: hypotension as a key point. Vasc Health Risk Manag 4: 395-402, 2008.
34. Ng PH, Walters WA. The effects of chronic maternal hypotension during pregnancy. AustNZJObstet Gynaecol 32: 14-16, 1992.
35. Ni Y, Meyer M, Osol G. Gestation increases nitric oxide-mediated vasodilation in rat uterine arteries. Am J Obstet Gynecol 176: 856-864, 1997.
36. O'Brien JM Jr, Ali NA, Aberegg SK, Abraham E. Sepsis. Am J Med 120: 1012-1022, 2007.
37. Osol G, Celia G, Gokina N, Barron C, Chien E, Mandala M, Luksha L, Kublickiene K. Placental growth factor is a potent vasodilator of rat and human resistance arteries. Am J Physiol Heart Circ Physiol 294: H1381-H1387, 2008.
38. Paller MS, Gregorini G, Ferris TF. Pressor responsiveness in pseudo- pregnant and pregnant rats: role of maternal factors. Am J Physiol Regul Integr Comp Physiol 257: R866-R871, 1989.
39. Pallotto EK, Kilbride HW. Perinatal outcome and later implications of intrauterine growth restriction. Clin Obstet Gynecol 49: 257-269, 2006.
40. Palmer SK, Zamudio S, Coffin C, Parker S, Stamm E, Moore LG. Quantitative estimation of human uterine artery blood flow and pelvic blood flow redistribution in pregnancy. Obstet Gynecol 80: 1000-1006, 1992.
41. Parent A, Schiffrin EL, St-Louis J. Role of the endothelium in adren- ergic responses of mesenteric artery rings of pregnant rats. Am J Obstet Gynecol 163: 229-234, 1990.
42. Petrakopoulou P, Kubrich M, Pehlivanli S, Meiser B, Reichart B, von Scheidt W, Weis M. Cytomegalovirus infection in heart transplant recipients is associated with impaired endothelial function. Circulation 110: II207-II212, 2004.
43. Roberts JM, Gammill HS. Preeclampsia: recent insights. Hypertension 46: 1243-1249, 2005.
44. Shen YH, Zhang L, Utama B, Wang J, Gan Y, Wang X, Chen L, Vercellotti GM, Coselli JS, Mehta JL, Wang XL. Human cytomegalo- virus inhibits Akt-mediated eNOS activation through upregulating PTEN (phosphatase and tensin homolog deleted on chromosome 10). Cardiovasc Res 69: 502-511, 2006.
45. Sholook MM, Gilbert JS, Sedeek MH, Huang M, Hester RL, Granger JP. Systemic hemodynamic and regional blood flow changes in response to chronic reductions in uterine perfusion pressure in pregnant rats. Am J Physiol Heart Circ Physiol 293: H2080-H2084, 2007.
46. Speir E, Shibutani T, Yu ZX, Ferrans V, Epstein SE. Role of reactive oxygen intermediates in cytomegalovirus gene expression and in the response of human smooth muscle cells to viral infection. Circ Res 79: 1143-1152, 1996.
47. Stoddart CA, Cardin RD, Boname JM, Manning WC, Abenes GB, Mocarski ES. Peripheral blood mononuclear phagocytes mediate dissemination of murine cytomegalovirus. J Virol 68: 6243-6253, 1994.
48. Sweet C. The pathogenicity of cytomegalovirus. FEMS Microbiol Rev 23: 457-482, 1999.
49. Veerareddy S, Cooke CL, Baker PN, Davidge ST. Vascular adaptations to pregnancy in mice: effects on myogenic tone. Am J Physiol Heart Circ Physiol 283: H2226-H2233, 2002.
50. von Dadelszen P, Magee LA, Krajden M, Alasaly K, Popovska V, Devarakonda RM, Money DM, Patrick DM, Brunham RC. Levels of antibodies against cytomegalovirus and Chlamydophila pneumoniae are increased in early onset pre-eclampsia. BJOG 110: 725-730, 2003.
51. von Muller L, Mertens T. Human cytomegalovirus infection and antiviral immunity in septic patients without canonical immunosuppression. Med Microbiol Immunol (Berl) 197: 75-82, 2008.
52. Walton SM, Wyrsch P, Munks MW, Zimmermann A, Hengel H, Hill AB, Oxenius A. The dynamics of mouse cytomegalovirus-specific CD4 T cell responses during acute and latent infection. J Immunol 181: 11281134, 2008.
53. Weiner CP, Thompson LP, Liu KZ, Herrig JE. Endothelium-derived relaxing factor and indomethacin-sensitive contracting factor alter arterial contractile responses to thromboxane during pregnancy. Am J Obstet Gynecol 166: 1171-1178; discussion 1179-1181, 1992.'
54. Weis M, Kledal TN, Lin KY, Panchal SN, Gao SZ, Valantine HA, Mocarski ES, Cooke JP. Cytomegalovirus infection impairs the nitric oxide synthase pathway: role of asymmetric dimethylarginine in transplant arteriosclerosis. Circulation 109: 500 -505, 2004.
55. Xiong X, Demianczuk NN, Saunders LD, Wang FL, Fraser WD. Impact of preeclampsia and gestational hypertension on birth weight by gestational age. Am J Epidemiol 155: 203-209, 2002.
56. Zamudio S, Palmer SK, Droma T, Stamm E, Coffin C, Moore LG. Effect of altitude on uterine artery blood flow during normal pregnancy. J Appl Physiol 79: 7-14, 1995.
57. Zhou YF, Shou M, Guetta E, Guzman R, Unger EF, Yu ZX, Zhang J, Finkel T, Epstein SE. Cytomegalovirus infection of rats increases the neointimal response to vascular injury without consistent evidence of direct infection of the vascular wall. Circulation 100: 1569 -1575, 1999.
58. Zhu H, Cong JP, Shenk T. Use of differential display analysis to assess the effect of human cytomegalovirus infection on the accumulation of cellular RNAs: induction of interferon-responsive RNAs. Proc Natl Acad Sci USA 94: 13985-13990, 1997.
59. Zhu H, Cong JP, Yu D, Bresnahan WA, Shenk TE. Inhibition of cyclooxygenase 2 blocks human cytomegalovirus replication. Proc Natl Acad Sci USA 99: 3932-3937, 2002.